Adult and children nasal drops: Rhinitis sicca, hypersensitivity to the active ingredient or to any of the excipients, children below six years of age.
Because of the benzalkonium chloride which is contained as preservative Iliadin 0.05% and 0.025% Decongestant Nasal Drops must not be used in known hypersensitivity to this substance.
Infant nasal drops: Rhinitis sicca, hypersensitivity to the active ingredient or one of the other ingredients.
Medical supervision is indicated in premature or underweight newborns to avoid the risk of overdosage.
Medical supervision is indicated in patients with chronic rhinitis.
In the following cases this drug may only be used after carefully weighing the risk-to-benefit ratio: Patients treated with monoamine oxidase inhibitors (MAO-inhibitors) and other drugs potentially increasing blood pressure.
Increased intraocular pressure, especially narrow-angle glaucoma.
Severe cardiovascular diseases (e.g. coronary heart disease, hypertension).
Metabolic disorders (e.g. hyperthyroidism, diabetes mellitus, porphyria).
Hyperplasia of the prostate.